Penetratin, Antp, Sequence 3 from Patent US 20030077289

General Information


DRACP ID  DRACP01237

Peptide Name   Penetratin, Antp, Sequence 3 from Patent US 20030077289

Sequence  RQIKIWFQNRRMKWKK

Sequence Length  16

UniProt ID  P31256  Q28599  P31262  Q28600  P15860  P09636  P18865  P09637  P07548  P09077  P81192  Q24645  P02833  Q1KKX9  O13074  Q9PWD3  Q1KKX0  P09013  Q9IA23  P09014  Q1KL14  Q1KKY0  A2D5Y4  P20719  A2D5K9   

PubChem CID  25242319 

Origin  Antennapedia homeodomain

Type  Native peptide

Classification

  

Cell-penetrating peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa WT Human papillomavirus-related endocervical adenocarcinoma Carcinoma 50% Cytotoxicity=281 ± 56.5 μM MTS/PMS assay 1 h 1

Hemolytic Activity  Human erythrocytes: HD50>128 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  1KZ0  2ND6  2NZZ  4XIC  1SAN  9ANT  1AHD  1HOM  2R5Y 

Predicted Structure  DRACP01237

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C104H168N34O20S

Absent amino acids  ACDEGHLPSTVY

Common amino acids  K

Mass  251448

Pl  12.83

Basic residues  7

Acidic residues  0

Hydrophobic residues  5

Net charge  7

Boman Index  -6485

Hydrophobicity  -173.13

Aliphatic Index  48.75

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  11000

Absorbance 280nm  733.33

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23085001

Title  Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure

Doi 10.1016/j.bbamem.2012.10.010

Year  2013

Patent

Patent ID US 2003/0077289 A1

Patent Title  Use of cell-penetrating peptides to generate antitumor immunity.

Other Iinformation  Granted Patent Family: 6s / 6ex; Family Jurisdictions: CN, WO, AU, US; Legal Status: Discontinued; Application No: 7755502; Filed:Feb 15, 2002; Published: Apr 24, 2003; Earliest Priority: Feb 15, 2001

Other Published ID  CN1309417C  CN1503628A  WO2002064057A2  WO2002064057A3 




DBAASP ID  DBAASPS_6203

DRACP is developed by Dr.Zheng's team.